1. Home
  2. TSLX vs EVO Comparison

TSLX vs EVO Comparison

Compare TSLX & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sixth Street Specialty Lending Inc.

TSLX

Sixth Street Specialty Lending Inc.

HOLD

Current Price

$18.77

Market Cap

1.6B

Sector

Finance

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$1.96

Market Cap

778.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TSLX
EVO
Founded
2010
1993
Country
United States
Germany
Employees
N/A
4553
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
778.3M
IPO Year
2011
2007

Fundamental Metrics

Financial Performance
Metric
TSLX
EVO
Price
$18.77
$1.96
Analyst Decision
Buy
Strong Buy
Analyst Count
9
1
Target Price
$21.61
$7.00
AVG Volume (30 Days)
474.4K
47.3K
Earning Date
05-05-2026
04-08-2026
Dividend Yield
10.82%
N/A
EPS Growth
N/A
N/A
EPS
0.15
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$1.37
Revenue Next Year
$1.20
$10.05
P/E Ratio
$127.80
N/A
Revenue Growth
N/A
N/A
52 Week Low
$16.04
$1.90
52 Week High
$24.79
$4.27

Technical Indicators

Market Signals
Indicator
TSLX
EVO
Relative Strength Index (RSI) 62.44 38.88
Support Level $17.20 $1.90
Resistance Level $19.75 $3.84
Average True Range (ATR) 0.46 0.05
MACD 0.13 0.04
Stochastic Oscillator 80.00 21.31

Price Performance

Historical Comparison
TSLX
EVO

About TSLX Sixth Street Specialty Lending Inc.

Sixth Street Specialty Lending Inc is a specialty finance company focused on providing flexible, fully committed financing solutions to middle market companies located in the United States of America. The company partners with other companies across a variety of industries and provides creative solutions with complex business models that may have limited access to capital. The company seeks to generate current income in U.S.-domiciled middle-market companies through direct originations of senior secured loans and, to a lesser extent, originations of mezzanine and unsecured loans and investments in corporate bonds and equity securities.

About EVO Evotec SE

Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other partners. It operates across drug discovery, preclinical development, and manufacturing, with expertise in areas including oncology, central nervous system, cardiovascular-renal, immune and inflammatory, infectious, and other diseases. The Company generates revenue through fee-for-service and FTE-based services, milestones, and royalties, and equity ownership in biotechnology and academic projects. It operates through the Shared R&D and Discovery & Preclinical Development (D&PD) segments, with the majority of revenue generated from the USA.

Share on Social Networks: